PRO-XTEN
LIVE

Serial Number

98228513

Owner

Amunix Pharmaceuticals, Inc.

Attorney

Nicole E. Reifman

Filing Date

Oct 18, 2023

Add to watchlist:

No watchlists yet
View on USPTO

PRO-XTEN Trademark

Serial Number: 98228513 • Registration: 7692425

PRO-XTEN is a trademark filed by Amunix Pharmaceuticals, Inc. on October 18, 2023. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Amunix Pharmaceuticals, Inc. (6 trademarks)

2 Tower Pl, #1100
South San Francisco, CA 94080

Entity Type: 03

Trademark Details

Filing Date

October 18, 2023

Registration Date

February 18, 2025

Published for Opposition

December 31, 2024

Goods & Services

Scientific and technological services, namely, chemical, biological, medical, pharmaceutical and scientific research and development of vaccines and medicines; Scientific research in the nature of conducting of clinical trials for others; Scientific information services by providing scientific data in the field of oncology and immunology diseases.

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 18, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 18, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 31, 2024 NPUB
PUBLISHED FOR OPPOSITION
Dec 31, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 25, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 4, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 3, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 3, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 3, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Sep 5, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Sep 5, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 5, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jun 5, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jun 5, 2024 CNRT
ASSIGNED TO EXAMINER
Jun 4, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 24, 2023 NWOS
NEW APPLICATION ENTERED
Oct 21, 2023 NWAP